Mar 04, 2019
Battelle Shares Expertise on the Front Lines in the Fight Against Ebola in Africa
Jan 28, 2019
NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children's
Dec 13, 2018
Ridgeback Biotherapeutics LP announces licensing of mAb114, an experimental Ebola treatment, from the National Institute of Allergy and Infectious Diseases
Nov 09, 2018
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
Sep 28, 2018
MappBio Announces Contract with BARDA for Sudan Virus Medical Countermeasure
Aug 17, 2018
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure
May 30, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA's response efforts to the Ebola virus outbreak in the Democratic Republic of Congo
Mar 20, 2018
National Research Council contribution plays key role in newly approved Ebola vaccine
Dec 07, 2017
Scientists from SRI International and Collaborations Pharmaceuticals, Inc. Identify Potential New Ebola Virus Therapy
Oct 02, 2017
Profectus BioSciences Awarded NIH Contract for up to $22.25 Million to Develop Multi-Component Vaccine for Ebola, Marburg, and Lassa Viruses
Sep 25, 2017
Soligenix Announces $700,000 Subaward Supporting Development Collaboration on Thermostabilization of an Ebola Vaccine Candidate
Aug 01, 2017
Integrated BioTherapeutics, in Collaboration with The Scripps Research Institute, Receives NIH Funding to Develop a Rationally Designed Pan-Ebolavirus Vaccine